Shingen Nakamura

1.4k total citations
78 papers, 845 citations indexed

About

Shingen Nakamura is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Shingen Nakamura has authored 78 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 30 papers in Oncology and 25 papers in Molecular Biology. Recurrent topics in Shingen Nakamura's work include Multiple Myeloma Research and Treatments (33 papers), Peptidase Inhibition and Analysis (10 papers) and Cancer Mechanisms and Therapy (7 papers). Shingen Nakamura is often cited by papers focused on Multiple Myeloma Research and Treatments (33 papers), Peptidase Inhibition and Analysis (10 papers) and Cancer Mechanisms and Therapy (7 papers). Shingen Nakamura collaborates with scholars based in Japan, United States and South Korea. Shingen Nakamura's co-authors include Masahiro Abe, Hirokazu Miki, Takeshi Harada, Kumiko Kagawa, Toshio Matsumoto, Shiro Fujii, Shuji Ozaki, Asuka Oda, Kyoko Takeuchi and Hiroe Amou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Shingen Nakamura

68 papers receiving 830 citations

Peers

Shingen Nakamura
P. Brent Ferrell United States
Hiroaki Ohnishi Japan
Tina Bagratuni Greece
Xiujin Ye China
Toshiyuki Kitoh Japan
Toshihiro Fukushima Japan
Yoshihiro Kameoka Japan
Nicola Goekbuget Germany
Lionel D’Hondt Belgium
Jason H. Kurzer United States
P. Brent Ferrell United States
Shingen Nakamura
Citations per year, relative to Shingen Nakamura Shingen Nakamura (= 1×) peers P. Brent Ferrell

Countries citing papers authored by Shingen Nakamura

Since Specialization
Citations

This map shows the geographic impact of Shingen Nakamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingen Nakamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingen Nakamura more than expected).

Fields of papers citing papers by Shingen Nakamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingen Nakamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingen Nakamura. The network helps show where Shingen Nakamura may publish in the future.

Co-authorship network of co-authors of Shingen Nakamura

This figure shows the co-authorship network connecting the top 25 collaborators of Shingen Nakamura. A scholar is included among the top collaborators of Shingen Nakamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingen Nakamura. Shingen Nakamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamura, Shingen, et al.. (2025). False-Positive Galactomannan Test Results in Multiple Myeloma. Diseases. 13(4). 118–118.
2.
Harada, Takeshi, et al.. (2024). Acute myeloid leukemia developed through myeloproliferative features during immunosuppressive therapy for juvenile idiopathic arthritis. The Journal of Medical Investigation. 71(3.4). 335–339.
3.
Takao, Shoichiro, Michiko Yamashita, Kimiko Sogabe, et al.. (2024). Quality of skeletal muscles during allogeneic stem-cell transplantation: a pilot study. BMJ Supportive & Palliative Care. 15(5). 672–676.
4.
Yanagiya, Shin‐ichiro, Takeshi Honda, Hiroki Takanari, et al.. (2024). Raman microspectroscopy for label‐free diagnosis of amyloid light‐chain amyloidosis in various organs. Journal of Raman Spectroscopy. 55(7). 753–760. 2 indexed citations
5.
Inoue, Yusuke, Jumpei Teramachi, Asuka Oda, et al.. (2024). Elotuzumab‐mediated ADCC with Th1‐like Vγ9Vδ2 T cells to disrupt myeloma–osteoclast interaction. Cancer Science. 116(2). 559–563. 1 indexed citations
6.
Inoue, Yusuke, Asuka Oda, Kimiko Sogabe, et al.. (2024). Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid. International Journal of Hematology. 119(6). 626–630. 1 indexed citations
7.
8.
9.
10.
Teramachi, Jumpei, Hirokazu Miki, Shingen Nakamura, et al.. (2023). Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents. Journal of Bone and Mineral Metabolism. 41(3). 388–403. 11 indexed citations
11.
Yamada, Hiroki, Naoto Okada, Shingen Nakamura, et al.. (2022). A machine learning model using SNPs obtained from a genome-wide association study predicts the onset of vincristine-induced peripheral neuropathy. The Pharmacogenomics Journal. 22(4). 241–246. 1 indexed citations
12.
Kagawa, Kumiko, Takashi Saito, Kimiko Sogabe, et al.. (2021). Allogeneic haematopoietic stem cell transplantation—clinical outcomes: impact of leg muscle strength. BMJ Supportive & Palliative Care. 16(1). 180–187. 6 indexed citations
13.
Fukui, Makoto, Shingen Nakamura, Kimiko Sogabe, et al.. (2020). Involvement of oral bacteria and oral immunity as risk factors for chemotherapy-induced fever with neutropenia in patients with hematological cancer. International Journal of Hematology. 112(6). 851–859. 1 indexed citations
14.
Nakamura, Shingen, Momoyo Azuma, Kimiko Sogabe, et al.. (2018). Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome. Journal of Infection and Chemotherapy. 24(5). 389–392. 32 indexed citations
15.
16.
Harada, Takeshi, Shuji Ozaki, Asuka Oda, et al.. (2013). Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors. PLoS ONE. 8(12). e83905–e83905. 13 indexed citations
17.
Harada, Takeshi, Shuji Ozaki, Asuka Oda, et al.. (2013). Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma. International Journal of Hematology. 97(6). 743–748. 20 indexed citations
18.
Miki, Hirokazu, Shuji Ozaki, Shingen Nakamura, et al.. (2011). KRN5500, a spicamycin derivative, exerts anti‐myeloma effects through impairing both myeloma cells and osteoclasts. British Journal of Haematology. 155(3). 328–339. 4 indexed citations
19.
Takeuchi, Kyoko, Masahiro Abe, Masahiro Hiasa, et al.. (2010). TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth. PLoS ONE. 5(3). e9870–e9870. 108 indexed citations
20.
Yamaguchi, Motoko, Naoya Nakamura, Ritsuro Suzuki, et al.. (2008). De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients. Haematologica. 93(8). 1195–1202. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Brent Ferrell Breakdown of academic impact, for papers by Hiroaki Ohnishi Breakdown of academic impact, for papers by Tina Bagratuni Breakdown of academic impact, for papers by Xiujin Ye Breakdown of academic impact, for papers by Toshiyuki Kitoh Breakdown of academic impact, for papers by Toshihiro Fukushima Breakdown of academic impact, for papers by Yoshihiro Kameoka Breakdown of academic impact, for papers by Nicola Goekbuget Breakdown of academic impact, for papers by Lionel D’Hondt Breakdown of academic impact, for papers by Jason H. Kurzer
Rankless by CCL
2026